COVID-19大流行期间围产期孕产妇心理健康与24 月龄时后代神经发育之间的关系

IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY
Anna Sindalovsky , Katherine Geisler , Heather G. Huddleston , Marcelle I. Cedars , Eleni G. Jaswa , Riley Huddleston , Maya Julian-Kwong , Jamie Corley , Elena Hoskin , Karla J. Lindquist
{"title":"COVID-19大流行期间围产期孕产妇心理健康与24 月龄时后代神经发育之间的关系","authors":"Anna Sindalovsky ,&nbsp;Katherine Geisler ,&nbsp;Heather G. Huddleston ,&nbsp;Marcelle I. Cedars ,&nbsp;Eleni G. Jaswa ,&nbsp;Riley Huddleston ,&nbsp;Maya Julian-Kwong ,&nbsp;Jamie Corley ,&nbsp;Elena Hoskin ,&nbsp;Karla J. Lindquist","doi":"10.1016/j.jad.2025.119884","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Prenatal anxiety and depression have been linked to adverse childhood neurodevelopment, potentially through cortisol-induced epigenetic changes. Postpartum depression is also associated with neurodevelopmental delays, possibly via altered parental attachment. While prenatal and postpartum mental health may be correlated, their relative and independent impacts on offspring neurodevelopment remain unclear. This study examines the effects of prenatal and postpartum anxiety and/or depression on neurodevelopmental delay at 24 months.</div></div><div><h3>Methods</h3><div>In a nationwide prospective cohort from the “Assessing the Safety of Pregnancy in the Coronavirus Pandemic” study, prenatal anxiety (GAD-7), prenatal depression (PHQ-9), and six-week postpartum depression (EPDS) were assessed. Childhood neurodevelopment was measured using the Ages and Stages Questionnaire, 3rd edition (ASQ-3). Logistic regression tested associations between moderate-to-severe maternal anxiety/depression and neurodevelopmental delay, adjusting for participant age, education, household income, and residential density. Alcohol, nicotine, anxiety/depression medication use during pregnancy, and preterm birth were considered as moderators/mediators.</div></div><div><h3>Results</h3><div>Offspring of participants experiencing both prenatal and postpartum moderate-to-severe anxiety or depression (<em>N</em> = 62) had a higher risk of neurodevelopmental delay at 24 months compared to those who experienced neither (<em>N</em> = 1060) with an adjusted risk ratio of 1.88 (<em>p</em> &lt; 0.001). While delay risk was higher in offspring of those with only prenatal (<em>N</em> = 218) or postpartum (<em>N</em> = 45) anxiety/depression, these were not statistically significant.</div></div><div><h3>Conclusion</h3><div>Having both moderate-to-severe prenatal and postpartum anxiety or depression independently increased the risk of developmental delay at 24 months, even after adjusting for confounders. Further research is needed to explore underlying mechanisms linking maternal mental health and fetal neurodevelopment.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"391 ","pages":"Article 119884"},"PeriodicalIF":4.9000,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The association between perinatal maternal mental health during the COVID-19 pandemic and offspring neurodevelopment at 24 months of age\",\"authors\":\"Anna Sindalovsky ,&nbsp;Katherine Geisler ,&nbsp;Heather G. Huddleston ,&nbsp;Marcelle I. Cedars ,&nbsp;Eleni G. Jaswa ,&nbsp;Riley Huddleston ,&nbsp;Maya Julian-Kwong ,&nbsp;Jamie Corley ,&nbsp;Elena Hoskin ,&nbsp;Karla J. Lindquist\",\"doi\":\"10.1016/j.jad.2025.119884\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Prenatal anxiety and depression have been linked to adverse childhood neurodevelopment, potentially through cortisol-induced epigenetic changes. Postpartum depression is also associated with neurodevelopmental delays, possibly via altered parental attachment. While prenatal and postpartum mental health may be correlated, their relative and independent impacts on offspring neurodevelopment remain unclear. This study examines the effects of prenatal and postpartum anxiety and/or depression on neurodevelopmental delay at 24 months.</div></div><div><h3>Methods</h3><div>In a nationwide prospective cohort from the “Assessing the Safety of Pregnancy in the Coronavirus Pandemic” study, prenatal anxiety (GAD-7), prenatal depression (PHQ-9), and six-week postpartum depression (EPDS) were assessed. Childhood neurodevelopment was measured using the Ages and Stages Questionnaire, 3rd edition (ASQ-3). Logistic regression tested associations between moderate-to-severe maternal anxiety/depression and neurodevelopmental delay, adjusting for participant age, education, household income, and residential density. Alcohol, nicotine, anxiety/depression medication use during pregnancy, and preterm birth were considered as moderators/mediators.</div></div><div><h3>Results</h3><div>Offspring of participants experiencing both prenatal and postpartum moderate-to-severe anxiety or depression (<em>N</em> = 62) had a higher risk of neurodevelopmental delay at 24 months compared to those who experienced neither (<em>N</em> = 1060) with an adjusted risk ratio of 1.88 (<em>p</em> &lt; 0.001). While delay risk was higher in offspring of those with only prenatal (<em>N</em> = 218) or postpartum (<em>N</em> = 45) anxiety/depression, these were not statistically significant.</div></div><div><h3>Conclusion</h3><div>Having both moderate-to-severe prenatal and postpartum anxiety or depression independently increased the risk of developmental delay at 24 months, even after adjusting for confounders. Further research is needed to explore underlying mechanisms linking maternal mental health and fetal neurodevelopment.</div></div>\",\"PeriodicalId\":14963,\"journal\":{\"name\":\"Journal of affective disorders\",\"volume\":\"391 \",\"pages\":\"Article 119884\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-07-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of affective disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165032725013266\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165032725013266","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:产前焦虑和抑郁与儿童神经发育不良有关,可能通过皮质醇诱导的表观遗传改变。产后抑郁症也与神经发育迟缓有关,可能通过改变父母依恋。虽然产前和产后心理健康可能相关,但它们对后代神经发育的相对和独立影响尚不清楚。本研究考察了产前和产后焦虑和/或抑郁对24 个月时神经发育迟缓的影响。方法:在一项来自“冠状病毒大流行期间妊娠安全性评估”研究的全国前瞻性队列中,评估产前焦虑(GAD-7)、产前抑郁(PHQ-9)和产后6周抑郁(EPDS)。儿童神经发育采用第三版年龄和阶段问卷(ASQ-3)进行测量。Logistic回归检验了中重度母亲焦虑/抑郁与神经发育迟缓之间的关系,调整了参与者的年龄、教育程度、家庭收入和居住密度。酒精、尼古丁、孕期使用焦虑/抑郁药物和早产被认为是调节/中介因素。结果:产前和产后均经历过中至重度焦虑或抑郁(N = 62)的参与者的后代在24 个月时发生神经发育迟缓的风险高于未经历过(N = 1060)的参与者(p ),调整后的风险比为1.88 (p )。结论:即使在调整混杂因素后,产前和产后均经历过中至重度焦虑或抑郁的参与者的后代在24 个月时发生发育迟缓的风险也增加。需要进一步的研究来探索母亲心理健康和胎儿神经发育之间的潜在机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The association between perinatal maternal mental health during the COVID-19 pandemic and offspring neurodevelopment at 24 months of age

Background

Prenatal anxiety and depression have been linked to adverse childhood neurodevelopment, potentially through cortisol-induced epigenetic changes. Postpartum depression is also associated with neurodevelopmental delays, possibly via altered parental attachment. While prenatal and postpartum mental health may be correlated, their relative and independent impacts on offspring neurodevelopment remain unclear. This study examines the effects of prenatal and postpartum anxiety and/or depression on neurodevelopmental delay at 24 months.

Methods

In a nationwide prospective cohort from the “Assessing the Safety of Pregnancy in the Coronavirus Pandemic” study, prenatal anxiety (GAD-7), prenatal depression (PHQ-9), and six-week postpartum depression (EPDS) were assessed. Childhood neurodevelopment was measured using the Ages and Stages Questionnaire, 3rd edition (ASQ-3). Logistic regression tested associations between moderate-to-severe maternal anxiety/depression and neurodevelopmental delay, adjusting for participant age, education, household income, and residential density. Alcohol, nicotine, anxiety/depression medication use during pregnancy, and preterm birth were considered as moderators/mediators.

Results

Offspring of participants experiencing both prenatal and postpartum moderate-to-severe anxiety or depression (N = 62) had a higher risk of neurodevelopmental delay at 24 months compared to those who experienced neither (N = 1060) with an adjusted risk ratio of 1.88 (p < 0.001). While delay risk was higher in offspring of those with only prenatal (N = 218) or postpartum (N = 45) anxiety/depression, these were not statistically significant.

Conclusion

Having both moderate-to-severe prenatal and postpartum anxiety or depression independently increased the risk of developmental delay at 24 months, even after adjusting for confounders. Further research is needed to explore underlying mechanisms linking maternal mental health and fetal neurodevelopment.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of affective disorders
Journal of affective disorders 医学-精神病学
CiteScore
10.90
自引率
6.10%
发文量
1319
审稿时长
9.3 weeks
期刊介绍: The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信